Dilated cardiomyopathy following use of xenadrine EFX

Int J Immunopathol Pharmacol. 2016 Mar;29(1):137-9. doi: 10.1177/0394632015599701. Epub 2015 Dec 17.

Abstract

We describe a case of a 35-year-old man presented at the emergency room of our institution with acute onset of dyspnea and dizziness. He was a body builder and had been using Xenadrine EFX for weight loss reduction. The laboratory analyses were normal. A chest radiograph showed an enlarged cardiac silhouette with clear lung fields. Transtoracic two-dimensional color Doppler echocardiography revealed a diffuse hypokinesia with a marked decreased in systolic function and a high teledyastolic diameter. This case document the possible relation to use of Xenadrine EFX for weight loss and the recurrence of dilated cardiomyopathy.

Keywords: dilated cardiomyopathy; weight loss; xenadrine.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Obesity Agents / adverse effects*
  • Cardiomyopathy, Dilated / chemically induced*
  • Ephedra / adverse effects*
  • Humans
  • Male

Substances

  • Anti-Obesity Agents